hypoglycaemia

This page shows the latest hypoglycaemia news and features for those working in and with pharma, biotech and healthcare.

Novo says real-world data backs its insulin switching

Rates of overall hypoglycaemia were also significantly lower after switching to Tresiba, falling 85% in type 1 and 92% in type 2 patients at six months. ... compare the two drugs on not only glucose control and hypoglycaemia but also cardiovascular

Latest news

Novo Nordisk's long-acting haemophilia B drug cleared by FDA

likely to cause low blood sugar levels or hypoglycaemia in patients with type 2 diabetes compared to Sanofi's Lantus.
Novo seeks to strengthen Tresiba label in US

An earlier study - called SWITCH 2 - also found an advantage for Tresiba over Lantus on hypoglycaemia rates. ... The risk of severe hypoglycaemia is a major cause for people with type 2 diabetes not reaching their treatment targets," said Mads Krogsgaard
AstraZeneca's Forxiga set to be recommended by NICE

dose in combination with either metformin or insulin for patients unable to take sulphonylurea medicines or at significant risk of hypoglycaemia.
Novo Nordisk's Tresiba gaining ground in basal insulin market

Since then, Novo Nordisk has been trying to differentiate itself from the pack with new data showing lower rates of hypoglycaemia (low blood sugar) compared to Lantus, and the first-half
Novo creates online diabetes management resource

A new online information resource for people with diabetes has been created by Novo Nordisk, with the aim of improving the understanding of hypoglycaemia, or hypos.

More from news
Approximately 2 fully matching, plus 92 partially matching documents found.

Latest Intelligence

Interview: Peter Meeus, Novo Nordisk

end of last year and has demonstrated it is as effective in reducing blood glucose levels as is its rival Lantus from Sanofi, yet carries less risk of hypoglycaemia. ... In addition, Meeus highlighted a need to raise awareness among the healthcare
Interview: Pierre Chancel, Sanofi Diabetes

2 diabetes further reduce HbA1c, with the benefit of weight loss and limited risk of hypoglycaemia.”.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

How technology is shaping patient education

The simulation showed the high impact of mild hypoglycaemia (low blood sugar) on a patient; it made the viewer ‘ feel’ the symptoms of hypoglycaemia in various scenarios through a typical day

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Account Manager – Med Comms – London: Salary TBC

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Medical Writer - (London, Brighton or Copenhagen): Competitive

Editorial Director – Medical Education – Oxford: Negotiable

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Programme Executive: Salary TBC

Scientific Director: Great salary and bebefits

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior Account Manager or AD - Medical Communications: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Editor – Medical Education Agency – Bucks: Salary TBC

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Senior Medical Writer: Great salary and benefits

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Senior Medical Writer: Great salary and bebefits

Senior Account Manager – Med Comms – Kent: Salary TBC

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Account Manager / Account Director: Great salary and bebefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

The Holy Grail of HCP Access: This is the data you need to gain access....
No incentive for a cure: The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....